Lung Cancer Screening Program Quality Indicators-Review and Recommendations: An International Association for the Study of Lung Cancer Delphi Process Study
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Lung cancer screening quality indicators (QIs) were developed by experts to improve program quality and participant outcomes. These consensus-based QIs cover screening, diagnosis, treatment, and equity for high-risk individuals.
Area Of Science
- Pulmonology
- Radiology
- Public Health
- Oncology
Background
- Low-dose computed tomography (LDCT) for lung cancer screening (LCS) reduces mortality in high-risk populations.
- Evaluating and monitoring LCS programs is crucial for quality, efficiency, and patient outcomes.
- A lack of consensus on quality indicators (QIs) hinders effective LCS program evaluation.
Purpose Of The Study
- To develop a consensus set of quality indicators (QIs) for lung cancer screening (LCS) programs.
- To establish standardized metrics for evaluating LCS quality, efficiency, and participant outcomes.
- To provide a framework for the development and improvement of LCS initiatives.
Main Methods
- A Delphi process involving twenty multidisciplinary experts from the International Association for the Study of Lung Cancer.
- Consideration of 50 potential QIs through information/discussion sessions and two anonymous voting rounds.
- Consensus defined as 80% or more agreement (agree or strongly agree) on a five-point Likert scale.
Main Results
- Twenty essential and six desirable QIs were identified across 10 of 11 LCS pathway domains.
- Key domains include screening entry, smoking cessation, imaging, adherence, diagnosis, outcomes, harms, treatment, wait times, and equity.
- Specific QIs address screening eligibility, intervention offers, diagnostic assessments, adherence rates, detection rates, stage distribution, complications, treatment intent, wait times, and health equity.
Conclusions
- A consensus set of recommended LCS QIs has been established by expert review.
- These QIs provide a foundation for developing and enhancing lung cancer screening programs.
- Implementation of these QIs is advised to ensure and improve the quality of LCS initiatives.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Descriptive Statistics: These provide basic...
Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...